$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Neurorehabilitation in Parkinson's Disease: A Critical Review of Cognitive Rehabilitation Effects on Cognition and Brain 원문보기

Neural plasticity, v.2018, 2018년, pp.2651918 -   

Díez-Cirarda, María (Department of Methods and Experimental Psychology, Faculty of Psychology and Education, University of Deusto, Bilbao, Spain) ,  Ibarretxe-Bilbao, Naroa (Department of Methods and Experimental Psychology, Faculty of Psychology and Education, University of Deusto, Bilbao, Spain) ,  Peña, Javier (Department of Methods and Experimental Psychology, Faculty of Psychology and Education, University of Deusto, Bilbao, Spain) ,  Ojeda, Natalia (Department of Methods and Experimental Psychology, Faculty of Psychology and Education, University of Deusto, Bilbao, Spain)

Abstract AI-Helper 아이콘AI-Helper

Background Parkinson's disease (PD) patients experience cognitive impairment which has been related to reduced quality of life and functional disability. These symptoms usually progress until dementia occurs. Some studies have been published assessing the efficacy of cognitive treatments on improvin...

참고문헌 (45)

  1. 1 Hirsch L. Jette N. Frolkis A. Steeves T. Pringsheim T. The incidence of Parkinson’s disease: a systematic review and meta-analysis 2016 46 4 292 300 10.1159/000445751 2-s2.0-84964213291 27105081 

  2. 2 Xia R. Mao Z.-H. Progression of motor symptoms in Parkinson’s disease 2012 28 1 39 48 10.1007/s12264-012-1050-z 2-s2.0-84860578177 22233888 

  3. 3 Tolosa E. Gaig C. Santamaria J. Compta Y. Diagnosis and the premotor phase of Parkinson disease 2009 72 7 Supplement 2 S12 S20 10.1212/WNL.0b013e318198db11 2-s2.0-61949235512 19221308 

  4. 4 Muslimovic D. Post B. Speelman J. D. Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease 2005 65 8 1239 1245 10.1212/01.wnl.0000180516.69442.95 2-s2.0-27144549543 16247051 

  5. 5 Yarnall A. J. Breen D. P. Duncan G. W. Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study 2014 82 4 308 316 10.1212/WNL.0000000000000066 2-s2.0-84895770516 24363137 

  6. 6 Hely M. A. Reid W. G. J. Adena M. A. Halliday G. M. Morris J. G. L. The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years 2008 23 6 837 844 10.1002/mds.21956 2-s2.0-41149173996 18307261 

  7. 7 Hoogland J. Boel J. A. de Bie R. M. A. Mild cognitive impairment as a risk factor for Parkinson’s disease dementia 2017 32 7 1056 1065 10.1002/mds.27002 2-s2.0-85020485882 28605056 

  8. 8 Leroi I. McDonald K. Pantula H. Harbishettar V. Cognitive impairment in Parkinson disease: impact on quality of life, disability, and caregiver burden 2012 25 4 208 214 10.1177/0891988712464823 2-s2.0-84872331080 23172765 

  9. 9 Rosenthal E. Brennan L. Xie S. Association between cognition and function in patients with Parkinson disease with and without dementia 2010 25 9 1170 1176 10.1002/mds.23073 2-s2.0-77955072991 20310053 

  10. 10 Melzer T. R. Watts R. MacAskill M. R. Grey matter atrophy in cognitively impaired Parkinson’s disease 2012 83 2 188 194 10.1136/jnnp-2011-300828 2-s2.0-84855591193 21890574 

  11. 11 Duncan G. W. Firbank M. J. Yarnall A. J. Gray and white matter imaging: a biomarker for cognitive impairment in early Parkinson’s disease? 2016 31 1 103 110 10.1002/mds.26312 2-s2.0-84956813804 26202802 

  12. 12 Zheng Z. Shemmassian S. Wijekoon C. Kim W. Bookheimer S. Y. Pouratian N. DTI correlates of distinct cognitive impairments in Parkinson’s disease 2014 35 4 1325 1333 10.1002/hbm.22256 2-s2.0-84896405010 23417856 

  13. 13 Matsui H. Nishinaka K. Oda M. Niikawa H. Kubori T. Udaka F. Dementia in Parkinson’s disease: diffusion tensor imaging 2007 116 3 177 181 10.1111/j.1600-0404.2007.00838.x 2-s2.0-34547897402 17714331 

  14. 14 Rektor I. Svátková A. Vojtíšek L. White matter alterations in Parkinson’s disease with normal cognition precede grey matter atrophy 2018 13 1, article e0187939 10.1371/journal.pone.0187939 29304183 

  15. 15 Cabeza R. Nyberg L. Imaging cognition II: an empirical review of 275 PET and fMRI studies 2000 12 1 1 47 10.1162/08989290051137585 2-s2.0-0034054982 10769304 

  16. 16 Christopher L. Strafella A. P. Neuroimaging of brain changes associated with cognitive impairment in Parkinson’s disease 2013 7 2 225 240 10.1111/jnp.12015 2-s2.0-84883685662 23551844 

  17. 17 Williams-Gray C. H. Mason S. L. Evans J. R. The CamPaIGN study of Parkinson’s disease: 10-year outlook in an incident population-based cohort 2013 84 11 1258 1264 10.1136/jnnp-2013-305277 2-s2.0-84885666304 23781007 

  18. 18 Johnson D. K. Langford Z. Garnier-Villarreal M. Morris J. C. Galvin J. E. Onset of mild cognitive impairment in Parkinson disease 2016 30 2 127 133 10.1097/WAD.0000000000000088 2-s2.0-84973098817 25850732 

  19. 19 Ramírez–Ruiz B. Martí M. J. Tolosa E. Longitudinal evaluation of cerebral morphological changes in Parkinson’s disease with and without dementia 2005 252 11 1345 1352 10.1007/s00415-005-0864-2 2-s2.0-25144513700 15995795 

  20. 20 Zhang Y. Wu I. W. Tosun D. Foster E. Schuff N. the Parkinson’s Progression Markers Initiative Progression of regional microstructural degeneration in Parkinson’s disease: a multicenter diffusion tensor imaging study 2016 11 10, article e0165540 10.1371/journal.pone.0165540 2-s2.0-84994050091 27798653 

  21. 21 Huang C. Tang C. Feigin A. Changes in network activity with the progression of Parkinson’s disease 2007 130 7 1834 1846 10.1093/brain/awm086 2-s2.0-34447636064 17470495 

  22. 22 Segura B. Ibarretxe-Bilbao N. Sala-Llonch R. Progressive changes in a recognition memory network in Parkinson’s disease 2013 84 4 370 378 10.1136/jnnp-2012-302822 2-s2.0-84875215603 23117490 

  23. 23 Mak E. Su L. Williams G. B. O'Brien J. T. Neuroimaging correlates of cognitive impairment and dementia in Parkinson’s disease 2015 21 8 862 870 10.1016/j.parkreldis.2015.05.013 2-s2.0-84937520218 26004683 

  24. 24 Bahar-Fuchs A. Clare L. Woods B. Cognitive training and cognitive rehabilitation for persons with mild to moderate dementia of the Alzheimer’s or vascular type: a review 2013 5 4 p. 35 10.1186/alzrt189 2-s2.0-84881452421 23924584 

  25. 25 Wykes T. Spaulding W. D. Thinking about the future cognitive remediation therapy—what works and could we do better? 2011 37 Supplement 2 S80 S90 10.1093/schbul/sbr064 2-s2.0-80052193140 21860051 

  26. 26 Hindle J. V. Petrelli A. Clare L. Kalbe E. Nonpharmacological enhancement of cognitive function in Parkinson’s disease: a systematic review 2013 28 8 1034 1049 10.1002/mds.25377 2-s2.0-84881547362 23426759 

  27. 27 Biundo R. Weis L. Fiorenzato E. Antonini A. Cognitive rehabilitation in Parkinson’s disease: is it feasible? 2017 32 7 840 860 10.1093/arclin/acx092 2-s2.0-85034623365 28961738 

  28. 28 Walton C. C. Naismith S. L. Lampit A. Mowszowski L. Lewis S. J. G. Cognitive training in Parkinson’s disease: a theoretical perspective 2017 31 3 207 216 10.1177/1545968316680489 2-s2.0-85012926764 27899737 

  29. 29 Lawrence B. J. Gasson N. Bucks R. S. Troeung L. Loftus A. M. Cognitive training and noninvasive brain stimulation for cognition in Parkinson’s disease: a meta-analysis 2017 31 7 597 608 10.1177/1545968317712468 2-s2.0-85024118575 28583011 

  30. 30 Leung I. H. Cognitive training in Parkinson disease 2015 85 1 9 

  31. 31 Peña J. Ibarretxe-Bilbao N. García-Gorostiaga I. Gomez-Beldarrain M. A. Díez-Cirarda M. Ojeda N. Improving functional disability and cognition in Parkinson disease: randomized controlled trial 2014 83 23 2167 2174 10.1212/WNL.0000000000001043 2-s2.0-84925946588 25361785 

  32. 32 Petrelli A. Kaesberg S. Barbe M. T. Effects of cognitive training in Parkinson’s disease: a randomized controlled trial 2014 20 11 1196 1202 10.1016/j.parkreldis.2014.08.023 2-s2.0-84908565171 25242806 

  33. 33 Cerasa A. Gioia M. C. Salsone M. Neurofunctional correlates of attention rehabilitation in Parkinson’s disease: an explorative study 2014 35 8 1173 1180 10.1007/s10072-014-1666-z 2-s2.0-84905111038 24554416 

  34. 34 Edwards J. D. Hauser R. A. O'Connor M. L. Valdés E. G. Zesiewicz T. A. Uc E. Y. Randomized trial of cognitive speed of processing training in Parkinson disease 2013 81 15 1284 1290 10.1212/WNL.0b013e3182a823ba 2-s2.0-84888250286 24014503 

  35. 35 París A. P. Saleta H. G. de la Cruz Crespo Maraver M. Blind randomized controlled study of the efficacy of cognitive training in Parkinson’s disease 2011 26 7 1251 1258 10.1002/mds.23688 2-s2.0-79959350034 21442659 

  36. 36 Cella M. Preti A. Edwards C. Dow T. Wykes T. Cognitive remediation for negative symptoms of schizophrenia: a network meta-analysis 2017 52 43 51 10.1016/j.cpr.2016.11.009 2-s2.0-85000613303 27930934 

  37. 37 Zimmermann R. Gschwandtner U. Benz N. Cognitive training in Parkinson disease: cognition-specific vs nonspecific computer training 2014 82 14 1219 1226 10.1212/WNL.0000000000000287 2-s2.0-84902154474 24623840 

  38. 38 Díez-Cirarda M. Ojeda N. Peña J. Increased brain connectivity and activation after cognitive rehabilitation in Parkinson’s disease: a randomized controlled trial 2017 11 6 1640 1651 10.1007/s11682-016-9639-x 2-s2.0-84991713187 27757820 

  39. 39 Sinforiani E. Banchieri L. Zucchella C. Pacchetti C. Sandrini G. Cognitive rehabilitation in Parkinson’s disease 2004 38 387 391 10.1016/j.archger.2004.04.049 2-s2.0-3042590009 15207437 

  40. 40 Reuter I. Mehnert S. Sammer G. Oechsner M. Engelhardt M. Efficacy of a multimodal cognitive rehabilitation including psychomotor and endurance training in Parkinson’s disease 2012 2012 15 235765 10.1155/2012/235765 2-s2.0-84867776384 23008772 

  41. 41 Díez-Cirarda M. Ojeda N. Peña J. Long-term effects of cognitive rehabilitation on brain, functional outcome and cognition in Parkinson’s disease 2018 25 1 5 12 10.1111/ene.13472 2-s2.0-85031746874 28940855 

  42. 42 Petrelli A. Kaesberg S. Barbe M. T. Cognitive training in Parkinson’s disease reduces cognitive decline in the long term 2015 22 4 640 647 10.1111/ene.12621 2-s2.0-84924299967 25534579 

  43. 43 Hindle J. V. Watermeyer T. J. Roberts J. Cognitive rehabilitation for Parkinson’s disease dementia: a study protocol for a pilot randomised controlled trial 2016 17 1 p. 152 10.1186/s13063-016-1253-0 2-s2.0-84962476699 27000036 

  44. 44 A’Campo L. E. I. Spliethoff-Kamminga N. G. A. Macht M. Roos R. A. C. The EduPark Consortium Caregiver education in Parkinson’s disease: formative evaluation of a standardized program in seven European countries 2010 19 1 55 64 10.1007/s11136-009-9559-y 2-s2.0-75149195733 19946755 

  45. 45 Adamski N. Adler M. Opwis K. Penner I. K. A pilot study on the benefit of cognitive rehabilitation in Parkinson’s disease 2016 9 3 153 164 10.1177/1756285616628765 2-s2.0-84962215990 27134671 

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로